12 February 2018 - PHARMAC is pleased to announce a quadrivalent influenza vaccine will be supplied for the 2018 influenza season. A quadrivalent influenza vaccine provides protection against four strains of influenza (two Influenza A and two Influenza B strains).
This was the subject of a previous notification letter dated 5 August 2016, detailing that Mylan EPD would be the funded influenza vaccine supplier for the 2017, 2018 and 2019 seasons and would supply a quadrivalent influenza vaccine in the first full influenza season following its approval by Medsafe.